Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:MELE - BE0165385973 - Common Stock

56.7 EUR
0 (0%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, MELE scores 6 out of 10 in our fundamental rating. MELE was compared to 61 industry peers in the Semiconductors & Semiconductor Equipment industry. MELE scores excellent on profitability, but there are some minor concerns on its financial health. MELE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year MELE was profitable.
In the past year MELE had a positive cash flow from operations.
Each year in the past 5 years MELE has been profitable.
Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MELE has a better Return On Assets (14.20%) than 82.26% of its industry peers.
MELE's Return On Equity of 25.94% is fine compared to the rest of the industry. MELE outperforms 75.81% of its industry peers.
The Return On Invested Capital of MELE (15.69%) is better than 79.03% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MELE is significantly above the industry average of 14.58%.
The 3 year average ROIC (31.03%) for MELE is well above the current ROIC(15.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROIC 15.69%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

MELE has a Profit Margin (15.42%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MELE has grown nicely.
Looking at the Operating Margin, with a value of 18.29%, MELE is in line with its industry, outperforming 54.84% of the companies in the same industry.
MELE's Operating Margin has improved in the last couple of years.
MELE has a worse Gross Margin (40.24%) than 62.90% of its industry peers.
In the last couple of years the Gross Margin of MELE has grown nicely.
Industry RankSector Rank
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

MELE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
MELE has more shares outstanding than it did 5 years ago.
MELE has a worse debt/assets ratio than last year.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 6.16. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 6.16, MELE perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
MELE has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as MELE would need 3.48 years to pay back of all of its debts.
MELE has a Debt to FCF ratio of 3.48. This is comparable to the rest of the industry: MELE outperforms 41.94% of its industry peers.
MELE has a Debt/Equity ratio of 0.62. This is a neutral value indicating MELE is somewhat dependend on debt financing.
MELE has a worse Debt to Equity ratio (0.62) than 79.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Altman-Z 6.16
ROIC/WACC1.41
WACC11.14%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 5.59. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MELE (5.59) is better than 93.55% of its industry peers.
A Quick Ratio of 2.71 indicates that MELE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.71, MELE belongs to the best of the industry, outperforming 82.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.59
Quick Ratio 2.71
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.51%.
MELE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.04% yearly.
Looking at the last year, MELE shows a very negative growth in Revenue. The Revenue has decreased by -16.57% in the last year.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%

3.2 Future

The Earnings Per Share is expected to grow by 7.41% on average over the next years.
The Revenue is expected to grow by 5.53% on average over the next years.
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 21.16, which indicates a rather expensive current valuation of MELE.
Compared to the rest of the industry, the Price/Earnings ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 80.65% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MELE to the average of the S&P500 Index (26.59), we can say MELE is valued slightly cheaper.
MELE is valuated correctly with a Price/Forward Earnings ratio of 15.95.
Based on the Price/Forward Earnings ratio, MELE is valued cheaper than 82.26% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.03. MELE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.16
Fwd PE 15.95
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MELE is valued a bit cheaper than the industry average as 74.19% of the companies are valued more expensively.
85.48% of the companies in the same industry are more expensive than MELE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.78
EV/EBITDA 12.44
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.92
EPS Next 2Y-8.34%
EPS Next 3Y1.48%

4

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 2.33%.
Compared to an average industry Dividend Yield of 0.79, MELE pays a better dividend. On top of this MELE pays more dividend than 91.94% of the companies listed in the same industry.
MELE's Dividend Yield is a higher than the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 2.33%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 112.64% of its income as dividend. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP112.64%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (12/24/2025, 7:00:00 PM)

56.7

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners15.31%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.29B
Revenue(TTM)822.53M
Net Income(TTM)131.83M
Analysts75.79
Price Target72.18 (27.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.33%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP112.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.96%
Min EPS beat(2)-2.47%
Max EPS beat(2)42.38%
EPS beat(4)1
Avg EPS beat(4)-0.06%
Min EPS beat(4)-38.45%
Max EPS beat(4)42.38%
EPS beat(8)3
Avg EPS beat(8)-0.67%
EPS beat(12)6
Avg EPS beat(12)0.27%
EPS beat(16)10
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.71%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)3.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.74%
Revenue beat(12)3
Avg Revenue beat(12)-1.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.6%
PT rev (1m)-6.06%
PT rev (3m)-5.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.48%
EPS NY rev (1m)0.31%
EPS NY rev (3m)-0.66%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.21%
Valuation
Industry RankSector Rank
PE 21.16
Fwd PE 15.95
P/S 2.68
P/FCF 24.78
P/OCF 17.37
P/B 4.51
P/tB 4.52
EV/EBITDA 12.44
EPS(TTM)2.68
EY4.73%
EPS(NY)3.55
Fwd EY6.27%
FCF(TTM)2.29
FCFY4.04%
OCF(TTM)3.26
OCFY5.76%
SpS21.17
BVpS12.58
TBVpS12.55
PEG (NY)N/A
PEG (5Y)0.92
Graham Number27.54
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROCE 18.88%
ROIC 15.69%
ROICexc 16.36%
ROICexgc 16.39%
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
FCFM 10.81%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexgc growth 3Y-14.81%
ROICexgc growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Debt/EBITDA 1.52
Cap/Depr 77.5%
Cap/Sales 4.61%
Interest Coverage 14.77
Cash Conversion 63.61%
Profit Quality 70.12%
Current Ratio 5.59
Quick Ratio 2.71
Altman-Z 6.16
F-Score4
WACC11.14%
ROIC/WACC1.41
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
EPS Next Y-29.28%
EPS Next 2Y-8.34%
EPS Next 3Y1.48%
EPS Next 5Y7.41%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%
Revenue Next Year-10.45%
Revenue Next 2Y-1.26%
Revenue Next 3Y2.16%
Revenue Next 5Y5.53%
EBIT growth 1Y-40.01%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-16.89%
EBIT Next 3Y5.62%
EBIT Next 5Y7.46%
FCF growth 1Y533.33%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y213.78%
OCF growth 3Y7.8%
OCF growth 5Y13.55%

MELEXIS NV / MELE.BR FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELE.BR.


What is the valuation status for MELE stock?

ChartMill assigns a valuation rating of 6 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


How profitable is MELEXIS NV (MELE.BR) stock?

MELEXIS NV (MELE.BR) has a profitability rating of 7 / 10.


What is the financial health of MELEXIS NV (MELE.BR) stock?

The financial health rating of MELEXIS NV (MELE.BR) is 6 / 10.


Can you provide the dividend sustainability for MELE stock?

The dividend rating of MELEXIS NV (MELE.BR) is 4 / 10 and the dividend payout ratio is 112.64%.